# Letermovir for R+ Study

> **NCT07706166** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University of Wisconsin, Madison** · enrollment: 146 (estimated)

## Conditions studied

- Kidney Transplant
- Liver Transplant

## Interventions

- **DRUG:** Letermovir

## Key facts

- **NCT ID:** NCT07706166
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2029-09
- **Final completion:** 2029-09
- **Target enrollment:** 146 (ESTIMATED)
- **Last updated:** 2026-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07706166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07706166, "Letermovir for R+ Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07706166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*